A randomized phase II study of amifostine used as stem cell protectant in non-hodgkin lymphoma patients receiving cisplatin-based salvage chemotherapy prior to stem cell transplant.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples